Literature DB >> 27301195

Prevention of Distant Lung Metastasis After Photodynamic Therapy Application in a Breast Cancer Tumor Model.

João Paulo Figueiró Longo, Luis Alexandre Muehlmann, Ana Luisa Miranda-Vilela, Flávia Arruda Portilho, Ludmilla Regina de Souza, Jaqueline Rodrigues Silva, Zulmira Guerrero Marques Lacava, Anamelia Lorenzetti Bocca, Sacha Braun Chaves, Ricardo Bentes Azevedo.   

Abstract

The objective of this study was to investigate the activity of photodynamic therapy mediated by aluminum-chlorophthalocyanine contained in a polymeric nanostructured carrier composed by methyl vinyl ether-co-maleic anhydride (PVM/MA) against local subcutaneous breast cancer tumors and its effects against distant metastasis in a mouse tumor model. In our results, we observed a decrease in breast cancer tumor growth, prevention of distant lung metastases, and a significant increased survival in mice treated with photodynamic therapy. In addition to these results, we observed that tumor-bearing mice without treatment developed a significant extension of liver hematopoiesis that was significantly reduced in mice treated with photodynamic therapy. We hypothesized and showed that this reduction in (1) metastasis and (2) liver hematopoiesis may be related to the systemic activity of immature hematopoietic cells, specifically the myeloid-derived suppressor cells, which were suppressed in mice treated with photodynamic therapy. These cells produce a tolerogenic tumor environment that protects tumor tissues from immunological surveillance. Therefore, we suggest that photodynamic therapy could be employed in combination with other conventional therapies; such as surgery and radiotherapy, to improve the overall survival of patients diagnosed with breast cancer, as observed in our experimental resuIts.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301195     DOI: 10.1166/jbn.2016.2208

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  5 in total

1.  Photodynamic therapy mediated by nanoparticles Aluminum Chloro Phthalocyanine in oral squamous carcinoma cells.

Authors:  Lilian Mendes Borburema Cangussu; Ludmilla Regina de Souza; Marcela Gonçalves de Souza; Renato Sobral Monteiro Junior; Luis Alexandre Muehlmann; Paulo Narcizo de Souza; Lucyana Conceição Farias; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Lasers Med Sci       Date:  2022-02-04       Impact factor: 3.161

2.  A non-toxic approach for treatment of breast cancer and its metastases: capecitabine enhanced photodynamic therapy in a murine breast tumor model.

Authors:  Sanjay Anand; Anton Yasinchak; Taylor Bullock; Mukul Govande; Edward V Maytin
Journal:  J Cancer Metastasis Treat       Date:  2019-01-24

3.  Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma.

Authors:  Yang Gao; Qi Chang Zheng; Shidang Xu; Youyong Yuan; Xiang Cheng; Shuai Jiang; Qihong Yu; Zifang Song; Bin Liu; Min Li
Journal:  Theranostics       Date:  2019-02-12       Impact factor: 11.556

Review 4.  An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Authors:  Juan Zhang; Chengshi Jiang; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Hua Zhang; Luis Alexandre Muehlmann
Journal:  Acta Pharm Sin B       Date:  2017-09-22       Impact factor: 11.413

5.  Induction of Immunogenic Cell Death by Photodynamic Therapy Mediated by Aluminum-Phthalocyanine in Nanoemulsion.

Authors:  Mosar Corrêa Rodrigues; Wellington Tavares de Sousa Júnior; Thayná Mundim; Camilla Lepesqueur Costa Vale; Jaqueline Vaz de Oliveira; Rayane Ganassin; Thyago José Arruda Pacheco; José Athayde Vasconcelos Morais; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Luis Alexandre Muehlmann
Journal:  Pharmaceutics       Date:  2022-01-14       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.